Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

1,296

Participants

Timeline

Start Date

September 15, 2026

Primary Completion Date

September 15, 2027

Study Completion Date

September 15, 2027

Conditions
Human Papillomavirus (HPV) Vaccines
Interventions
BEHAVIORAL

Protect Me 4 Application + External Quality Improvement Support

Participants will be asked to interact with the Protect Me 4 application, using an iPad tablet. During the implementation period (months 4-6), intervention clinics will receive the Protect Me 4 app and External Quality Improvement Support (practice facilitation and external and internal provider peer opinion leaders and provider incentives). Providers from intervention clinics will complete audit and feedback reports to assess HPV vaccination rates with the assistance of the practice facilitator. Providers at the intervention clinic will complete a pre-intervention survey to obtain background information (demographics, approximate HPV vaccination rates, comfort with the use of technology etc.)

BEHAVIORAL

Protect Me 4 Application Alone

During the maintenance period (months 7-9), intervention clinics will receive Protect Me 4 without external support (practice facilitation and external provider peer opinion leaders). Providers from intervention clinics will complete audit and feedback reports to assess HPV vaccination rates without the assistance of the practice facilitator. Providers at the intervention clinic will complete a post-intervention survey to gain provider feedback regarding the feasibility of Protect Me 4 and changes in perceptions regarding the use of technology.

Trial Locations (1)

32611

University of Florida, Gainesville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

University of Florida

OTHER